相似文献
1
Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiary-care hospital in Mexico City, Mexico.
J Clin Microbiol. 2004 Sep;42(9):4321-2. doi: 10.1128/JCM.42.9.4321-4322.2004.
2
Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Ren Fail. 2006;28(8):729-35. doi: 10.1080/08860220600925602.
3
Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: a cross-sectional study.
Clin Nephrol. 1995 Jul;44(1):49-55.
4
HCV-RNA qualitative assay based on transcription mediated amplification improves the detection of hepatitis C virus infection in patients on hemodialysis: results from five hemodialysis units in central Greece.
J Clin Virol. 2005 Sep;34(1):81-5. doi: 10.1016/j.jcv.2005.05.007.
5
[Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
Nihon Jinzo Gakkai Shi. 1991 Oct;33(10):989-99.
6
Hepatitis C viral infection in a Chinese hemodialysis unit.
Chin Med J (Engl). 2010 Dec;123(24):3574-7.
7
[The presence of hepatitis C virus (HCV) infection in hemodialysis patients and determination of HCV genotype distribution].
Mikrobiyol Bul. 2002 Jul-Oct;36(3-4):291-300.
8
Prevalence of hepatitis C virus antibody in patients on chronic hemodialysis.
Fukuoka Igaku Zasshi. 1998 Aug;89(8):232-7.
9
[Viral hepatitis C in patients with terminal chronic renal insufficiency. III. Viral quantification].
Rev Invest Clin. 2001 Jan-Feb;53(1):21-7.
10
Hepatitis C infection in dialysis patients in Israel.
Isr Med Assoc J. 2001 Mar;3(3):174-7.
引用本文的文献
1
Prevalent coinfection and associated factors for Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus in patients submitted to renal replacement therapy: A cross-sectional study of 21 dialysis units in the State of Mexico.
PLoS One. 2022 Dec 1;17(12):e0275238. doi: 10.1371/journal.pone.0275238. eCollection 2022.
2
Molecular characterization and genotyping of hepatitis C virus from Sudanese end-stage renal disease patients on haemodialysis.
BMC Infect Dis. 2022 Nov 14;22(1):848. doi: 10.1186/s12879-022-07833-1.
3
Micro-elimination of Hepatitis C in Low- and Middle-Income Settings: Challenges and Windows of Opportunity.
Clin Liver Dis (Hoboken). 2021 Aug 10;19(2):38-40. doi: 10.1002/cld.1152. eCollection 2022 Feb.
4
A cross sectional study of the risk factors of hepatitis C infection in North Egypt.
Virusdisease. 2021 Mar;32(1):22-28. doi: 10.1007/s13337-020-00639-2. Epub 2021 Mar 20.
5
Management of hepatitis C virus infection in hemodialysis patients.
World J Hepatol. 2014 Jun 27;6(6):419-25. doi: 10.4254/wjh.v6.i6.419.
6
Incidence of CMV-HCV coinfection in renal transplant recipient.
BMJ Case Rep. 2012 Apr 2;2012:bcr1220115314. doi: 10.1136/bcr.12.2011.5314.
7
Hepatitis B and C in dialysis units in Kosova.
Virol J. 2009 Jun 4;6:72. doi: 10.1186/1743-422X-6-72.
8
A shield against a monster: Hepatitis C in hemodialysis patients.
World J Gastroenterol. 2009 Feb 14;15(6):641-6. doi: 10.3748/wjg.15.641.
9
Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S.
Salud Publica Mex. 2007 May-Jun;49(3):165-72. doi: 10.1590/s0036-36342007000300001.
10
Epidemiology of hepatitis C virus (HCV) infection.
Int J Med Sci. 2006;3(2):41-6. doi: 10.7150/ijms.3.41. Epub 2006 Apr 1.
本文引用的文献
1
A rational use of laboratory tests in the diagnosis and management of hepatitis C virus infection.
Ann Hepatol. 2003 Apr-Jun;2(2):76-83.
2
Chronic hepatitis C virus infection.
JAMA. 2003 May 14;289(18):2413-7. doi: 10.1001/jama.289.18.2413.
3
[Hepatitis C in Mexico].
Rev Gastroenterol Mex. 2002 Oct;67 Suppl 2:S7-8.
4
Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.
Clin Liver Dis. 2003 Feb;7(1):261-87. doi: 10.1016/s1089-3261(02)00078-8.
5
Hepatitis C virus genetic variability: pathogenic and clinical implications.
Clin Liver Dis. 2003 Feb;7(1):45-66. doi: 10.1016/s1089-3261(02)00065-x.
6
[National consensus on hepatitis C. Conclusions].
Rev Invest Clin. 2002 Nov-Dec;54(6):559-68.
7
Viraemia, cryoglobulins and autoantibodies in haemodialysis patients infected with hepatitis C virus.
Eur J Gastroenterol Hepatol. 2003 Feb;15(2):133-7. doi: 10.1097/00042737-200302000-00005.
8
Lack of seronegative hepatitis C virus infections in patients with chronic renal failure.
Transplantation. 2002 Nov 27;74(10):1473-5. doi: 10.1097/00007890-200211270-00022.
9
Characteristics of hepatitis C in renal transplant candidates.
J Clin Gastroenterol. 2002 Aug;35(2):191-5. doi: 10.1097/00004836-200208000-00013.
10
Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients.
Gut. 2002 Sep;51(3):429-33. doi: 10.1136/gut.51.3.429.
Zotero 插件